Healthcare Sector Stocks
The Healthcare sector has a total of 1066 stocks, with a combined market cap of $8.28 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 39.89.
Market Cap
8.28T
Revenue
4.52T
Profits
207.58B
PE Ratio
39.89
Profit Margin
4.59%
Dividend Yield
0.44%
1066 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 837.17B | - | 2,727,128 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 585.39B | - | 6,878,704 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 369.39B | - | 5,151,109 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 314.50B | - | 2,049,295 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 298.84B | - | 6,387,888 | 65.01B |
| 6 | NVS | Novartis AG | 294.55B | - | 2,630,988 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 251.66B | - | 6,407,008 | 447.57B |
| 8 | AMGN | Amgen Inc. | 187.56B | - | 1,604,274 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 182.57B | - | 1,696,350 | 44.56B |
| 10 | ABT | Abbott Laboratories | 179.16B | - | 5,453,795 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 173.41B | - | 4,925,897 | 29.44B |
| 12 | NVO | Novo Nordisk A/S | 163.33B | 1.37% | 14,695,847 | 48.59B |
| 13 | PFE | Pfizer Inc. | 161.09B | -0.81% | 30,920,609 | 62.58B |
| 14 | ISRG | Intuitive Surgical, Inc. | 160.56B | -2.67% | 1,647,820 | 10.06B |
| 15 | DHR | Danaher Corporation | 135.26B | - | 2,739,752 | 24.57B |
| 16 | SYK | Stryker Corporation | 126.88B | 0.65% | 1,485,922 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.69B | - | 14,752,811 | 48.19B |
| 18 | SNY | Sanofi | 115.12B | - | 1,518,953 | 54.85B |
| 19 | GSK | GSK plc | 113.45B | - | 3,877,549 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 111.45B | - | 1,244,992 | 12.00B |
| 21 | MDT | Medtronic plc | 111.22B | - | 4,687,667 | 35.48B |
| 22 | MCK | McKesson Corporation | 108.31B | - | 570,801 | 397.96B |
| 23 | HCA | HCA Healthcare, Inc. | 105.49B | - | 905,226 | 75.60B |
| 24 | CVS | CVS Health Corporation | 93.49B | - | 6,034,577 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 93.36B | - | 13,895,817 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.18B | - | 1,000,702 | 14.34B |
| 27 | CI | The Cigna Group | 71.19B | - | 904,639 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 66.06B | - | 1,192,537 | 199.13B |
| 29 | COR | Cencora, Inc. | 63.18B | - | 1,266,196 | 325.78B |
| 30 | MDLN | Medline Inc. | 58.17B | - | 6,506,378 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 56.97B | - | 2,642,256 | 28.48B |
| 32 | CAH | Cardinal Health, Inc. | 50.37B | - | 1,503,837 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 49.79B | - | 2,185,423 | 9.47B |
| 34 | EW | Edwards Lifesciences Corporation | 46.73B | - | 3,303,023 | 6.07B |
| 35 | ARGX | argenx SE | 46.37B | - | 372,102 | 4.24B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.35B | - | 734,284 | 4.30B |
| 37 | HLN | Haleon plc | 44.03B | - | 4,750,030 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 44.00B | - | 2,368,150 | 21.92B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.29B | - | 872,487 | 3.71B |
| 40 | ALC | Alcon Inc. | 36.84B | - | 1,279,771 | 10.40B |
| 41 | INSM | Insmed Incorporated | 35.06B | - | 1,809,386 | 606.42M |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 35.03B | - | 2,843,879 | 17.26B |
| 43 | ONC | BeOne Medicines AG | 34.46B | - | 133,532 | 5.34B |
| 44 | A | Agilent Technologies, Inc. | 32.63B | - | 1,111,945 | 7.07B |
| 45 | RMD | ResMed Inc. | 32.50B | - | 642,892 | 5.40B |
| 46 | GEHC | GE HealthCare Technologies Inc. | 32.10B | - | 2,751,116 | 20.63B |
| 47 | WAT | Waters Corporation | 29.85B | - | 727,269 | 3.17B |
| 48 | NTRA | Natera, Inc. | 29.48B | - | 1,280,031 | 2.31B |
| 49 | IQV | IQVIA Holdings Inc. | 29.08B | - | 794,291 | 16.31B |
| 50 | VEEV | Veeva Systems Inc. | 28.42B | - | 1,248,478 | 3.20B |
| 51 | RPRX | Royalty Pharma plc | 28.02B | - | 2,730,420 | 2.38B |
| 52 | BIIB | Biogen Inc. | 26.03B | - | 1,339,298 | 9.89B |
| 53 | PHG | Koninklijke Philips N.V. | 25.90B | - | 996,298 | 20.94B |
| 54 | MTD | Mettler-Toledo International Inc. | 25.51B | - | 87,733 | 4.03B |
| 55 | UTHR | United Therapeutics Corporation | 24.75B | -0.96% | 831,084 | 3.18B |
| 56 | DXCM | DexCom, Inc. | 23.95B | - | 2,407,723 | 4.66B |
| 57 | LH | Labcorp Holdings Inc. | 22.55B | - | 467,247 | 13.95B |
| 58 | BNTX | BioNTech SE | 21.88B | - | 786,749 | 3.37B |
| 59 | DGX | Quest Diagnostics Incorporated | 21.76B | - | 519,962 | 11.04B |
| 60 | STE | STERIS plc | 21.45B | - | 763,546 | 5.83B |
| 61 | HUM | Humana Inc. | 21.35B | - | 972,851 | 129.66B |
| 62 | ROIV | Roivant Sciences Ltd. | 20.28B | - | 5,013,733 | 13.31M |
| 63 | RVMD | Revolution Medicines, Inc. | 19.64B | - | 1,331,711 | - |
| 64 | MRNA | Moderna, Inc. | 19.51B | - | 4,631,751 | 1.94B |
| 65 | ILMN | Illumina, Inc. | 19.48B | - | 960,577 | 4.34B |
| 66 | INCY | Incyte Corporation | 19.09B | - | 1,160,053 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.35B | - | 795,052 | 3.07B |
| 68 | ZBH | Zimmer Biomet Holdings, Inc. | 17.59B | - | 2,164,782 | 8.23B |
| 69 | CNC | Centene Corporation | 17.27B | - | 4,832,139 | 176.15B |
| 70 | HOLX | Hologic, Inc. | 16.89B | - | 3,117,771 | 4.13B |
| 71 | GMAB | Genmab A/S | 16.77B | - | 1,081,616 | 3.72B |
| 72 | THC | Tenet Healthcare Corporation | 16.36B | - | 618,769 | 21.31B |
| 73 | VTRS | Viatris Inc. | 15.47B | - | 5,921,065 | 14.30B |
| 74 | RGC | Regencell Bioscience Holdings Limited | 15.23B | - | 330,047 | - |
| 75 | SMMT | Summit Therapeutics Inc. | 15.03B | 2.43% | 3,077,322 | - |
| 76 | PODD | Insulet Corporation | 14.38B | - | 886,803 | 2.71B |
| 77 | MEDP | Medpace Holdings, Inc. | 14.23B | - | 284,409 | 2.53B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 14.18B | - | 1,230,043 | 502.08M |
| 79 | ASND | Ascendis Pharma A/S | 14.07B | - | 754,686 | 845.52M |
| 80 | COO | The Cooper Companies, Inc. | 13.69B | - | 2,049,648 | 4.15B |
| 81 | SNN | Smith & Nephew plc | 13.65B | - | 854,597 | 6.16B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.21B | - | 706,967 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 12.99B | - | 747,863 | 1.40B |
| 84 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.55B | - | 345,032 | 958.40M |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.35B | - | 1,791,633 | 943.71M |
| 86 | GH | Guardant Health, Inc. | 12.31B | - | 1,744,127 | 982.02M |
| 87 | ALGN | Align Technology, Inc. | 12.16B | - | 1,081,611 | 4.03B |
| 88 | FMS | Fresenius Medical Care AG | 12.07B | - | 329,832 | 23.05B |
| 89 | GMED | Globus Medical, Inc. | 11.89B | - | 1,056,015 | 2.94B |
| 90 | JAZZ | Jazz Pharmaceuticals plc | 11.51B | - | 695,901 | 4.27B |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.47B | - | 4,254,883 | 4.72B |
| 92 | EXEL | Exelixis, Inc. | 11.40B | - | 1,664,733 | 2.32B |
| 93 | ENSG | The Ensign Group, Inc. | 11.34B | - | 366,271 | 5.06B |
| 94 | SOLV | Solventum Corporation | 11.02B | - | 1,046,683 | 8.33B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 10.90B | - | 4,179,353 | 3.85B |
| 96 | UHS | Universal Health Services, Inc. | 10.79B | - | 547,004 | 17.36B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.67B | - | 2,315,876 | 3.22B |
| 98 | RVTY | Revvity, Inc. | 9.94B | - | 949,753 | 2.86B |
| 99 | DVA | DaVita Inc. | 9.72B | - | 1,141,552 | 13.64B |
| 100 | EHC | Encompass Health Corporation | 9.68B | - | 804,114 | 5.94B |
| 101 | MASI | Masimo Corporation | 9.32B | - | 1,008,960 | 1.53B |
| 102 | ABVX | ABIVAX Société Anonyme | 9.27B | - | 963,117 | 5.37M |
| 103 | BTSG | BrightSpring Health Services, Inc. | 8.80B | - | 1,684,424 | 12.91B |
| 104 | ICLR | ICON Public Limited Company | 8.72B | - | 661,195 | 8.10B |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 8.64B | - | 300,229 | 7.46M |
| 106 | AXSM | Axsome Therapeutics, Inc. | 8.62B | - | 617,094 | 638.50M |
| 107 | BAX | Baxter International Inc. | 8.61B | - | 6,513,625 | 11.24B |
| 108 | CRL | Charles River Laboratories International, Inc. | 8.56B | - | 839,210 | 4.02B |
| 109 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.55B | - | 1,451,847 | 1.09B |
| 110 | HSIC | Henry Schein, Inc. | 8.48B | - | 1,203,087 | 13.18B |
| 111 | TEM | Tempus AI, Inc. | 8.47B | 0.77% | 3,833,272 | 1.27B |
| 112 | QGEN | Qiagen N.V. | 8.46B | - | 1,276,363 | 2.09B |
| 113 | PCVX | Vaxcyte, Inc. | 8.40B | - | 1,017,837 | - |
| 114 | TECH | Bio-Techne Corporation | 8.31B | - | 1,802,225 | 1.22B |
| 115 | NUVL | Nuvalent, Inc. | 8.29B | - | 992,146 | - |
| 116 | CYTK | Cytokinetics, Incorporated | 8.22B | - | 2,479,315 | 88.04M |
| 117 | ATR | AptarGroup, Inc. | 8.04B | - | 297,467 | 3.78B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 7.64B | - | 1,523,429 | 1.40B |
| 119 | KRYS | Krystal Biotech, Inc. | 7.63B | - | 203,765 | 389.13M |
| 120 | BIO | Bio-Rad Laboratories, Inc. | 7.56B | - | 253,681 | 2.58B |
| 121 | IBRX | ImmunityBio, Inc. | 7.54B | 2.24% | 14,223,092 | 113.29M |
| 122 | MOH | Molina Healthcare, Inc. | 7.26B | - | 1,283,659 | 43.56B |
| 123 | HQY | HealthEquity, Inc. | 7.15B | - | 640,306 | 1.31B |
| 124 | KYMR | Kymera Therapeutics, Inc. | 6.97B | - | 690,925 | 39.21M |
| 125 | ACLX | Arcellx, Inc. | 6.73B | - | 1,212,170 | 22.29M |
| 126 | BLTE | Belite Bio, Inc | 6.68B | - | 213,954 | - |
| 127 | RGEN | Repligen Corporation | 6.63B | - | 797,307 | 738.26M |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.62B | - | 601,602 | 46.02M |
| 129 | GRFS | Grifols, S.A. | 6.61B | - | 758,790 | 8.83B |
| 130 | GKOS | Glaukos Corporation | 6.55B | - | 591,427 | 507.44M |
| 131 | APGE | Apogee Therapeutics, Inc. | 6.23B | - | 676,804 | - |
| 132 | CNTA | Centessa Pharmaceuticals plc | 6.14B | - | 3,646,711 | 15.00M |
| 133 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | - | 10,851,346 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.89B | - | 546,431 | 189.76M |
| 135 | BLCO | Bausch + Lomb Corporation | 5.84B | - | 350,430 | 5.10B |
| 136 | ALKS | Alkermes plc | 5.79B | - | 2,485,561 | 1.48B |
| 137 | SRRK | Scholar Rock Holding Corporation | 5.75B | - | 2,026,317 | - |
| 138 | CGON | CG Oncology, Inc. | 5.70B | - | 1,278,720 | 4.04M |
| 139 | MIRM | Mirum Pharmaceuticals, Inc. | 5.68B | - | 742,924 | 521.31M |
| 140 | COGT | Cogent Biosciences, Inc. | 5.67B | - | 1,968,329 | - |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.61B | - | 483,034 | 1.73B |
| 142 | BRKR | Bruker Corporation | 5.60B | - | 1,458,956 | 3.44B |
| 143 | ERAS | Erasca, Inc. | 5.54B | - | 5,480,026 | - |
| 144 | CAI | Caris Life Sciences, Inc. | 5.45B | - | 1,541,639 | 812.03M |
| 145 | CELC | Celcuity Inc. | 5.44B | - | 501,394 | - |
| 146 | XENE | Xenon Pharmaceuticals Inc. | 5.43B | - | 897,518 | 7.50M |
| 147 | AVTR | Avantor, Inc. | 5.34B | - | 5,095,117 | 6.55B |
| 148 | CHE | Chemed Corporation | 5.24B | - | 211,446 | 2.53B |
| 149 | TFX | Teleflex Incorporated | 5.21B | - | 493,485 | 1.99B |
| 150 | APLS | Apellis Pharmaceuticals, Inc. | 5.17B | - | 10,333,531 | 1.00B |
| 151 | PACS | PACS Group, Inc. | 5.05B | - | 586,954 | 5.29B |
| 152 | IMVT | Immunovant, Inc. | 4.99B | - | 2,025,011 | - |
| 153 | TGTX | TG Therapeutics, Inc. | 4.95B | - | 1,531,631 | 616.29M |
| 154 | LNTH | Lantheus Holdings, Inc. | 4.94B | - | 422,527 | 1.54B |
| 155 | CRSP | CRISPR Therapeutics AG | 4.75B | - | 1,727,877 | 3.51M |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 4.55B | - | 879,705 | 2.04M |
| 157 | WAY | Waystar Holding Corp. | 4.55B | - | 1,595,389 | 1.10B |
| 158 | FOLD | Amicus Therapeutics, Inc. | 4.53B | - | 2,991,131 | 634.21M |
| 159 | CORT | Corcept Therapeutics Incorporated | 4.52B | - | 1,498,234 | 761.41M |
| 160 | HIMS | Hims & Hers Health, Inc. | 4.36B | -3.53% | 23,511,979 | 2.35B |
| 161 | OPCH | Option Care Health, Inc. | 4.30B | - | 1,866,899 | 5.65B |
| 162 | SHC | Sotera Health Company | 4.25B | - | 3,980,086 | 1.16B |
| 163 | RDNT | RadNet, Inc. | 4.25B | - | 1,000,950 | 2.04B |
| 164 | NVST | Envista Holdings Corporation | 4.23B | - | 1,695,863 | 2.72B |
| 165 | DOCS | Doximity, Inc. | 4.21B | - | 2,401,746 | 637.78M |
| 166 | VKTX | Viking Therapeutics, Inc. | 4.03B | - | 3,602,021 | - |
| 167 | MMSI | Merit Medical Systems, Inc. | 4.02B | - | 580,285 | 1.52B |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 3.98B | - | 1,351,364 | 3.02B |
| 169 | LGND | Ligand Pharmaceuticals Incorporated | 3.98B | - | 221,927 | 268.09M |
| 170 | MMED | Minimed Group, Inc. | 3.93B | - | 725,601 | 2.89B |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.90B | - | 1,247,931 | 7.70M |
| 172 | ALHC | Alignment Healthcare, Inc. | 3.83B | - | 2,728,240 | 3.95B |
| 173 | NAMS | NewAmsterdam Pharma Company N.V. | 3.79B | - | 725,310 | 22.50M |
| 174 | GPCR | Structure Therapeutics Inc. | 3.79B | - | 1,708,669 | - |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | - | 1,702,907 | 1.07B |
| 176 | IRTC | iRhythm Holdings, Inc. | 3.77B | - | 344,788 | 747.14M |
| 177 | STVN | Stevanato Group S.p.A. | 3.75B | - | 447,646 | 1.39B |
| 178 | SYRE | Spyre Therapeutics, Inc. | 3.74B | - | 438,075 | - |
| 179 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.74B | - | 436,345 | 677.56M |
| 180 | BLLN | BillionToOne, Inc. | 3.65B | - | 362,723 | 305.11M |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 3.58B | - | 985,914 | - |
| 182 | OSCR | Oscar Health, Inc. | 3.55B | 1.62% | 4,372,225 | 11.70B |
| 183 | LEGN | Legend Biotech Corporation | 3.54B | - | 1,237,398 | 1.03B |
| 184 | LIVN | LivaNova PLC | 3.49B | - | 678,905 | 1.39B |
| 185 | TMDX | TransMedics Group, Inc. | 3.45B | - | 551,959 | 605.49M |
| 186 | LQDA | Liquidia Corporation | 3.32B | - | 786,682 | 158.32M |
| 187 | BKD | Brookdale Senior Living Inc. | 3.32B | - | 3,081,627 | 3.05B |
| 188 | DNLI | Denali Therapeutics Inc. | 3.27B | - | 1,625,806 | - |
| 189 | DYN | Dyne Therapeutics, Inc. | 3.11B | - | 1,939,740 | - |
| 190 | TNGX | Tango Therapeutics, Inc. | 3.09B | - | 2,924,659 | 62.38M |
| 191 | ICUI | ICU Medical, Inc. | 3.08B | - | 308,662 | 2.23B |
| 192 | TWST | Twist Bioscience Corporation | 3.08B | - | 970,717 | 391.56M |
| 193 | HNGE | Hinge Health, Inc. | 3.07B | - | 475,959 | 587.86M |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.03B | -1.19% | 170,292 | 803.79M |
| 195 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.02B | - | 616,268 | 588.99M |
| 196 | ITGR | Integer Holdings Corporation | 2.99B | - | 329,798 | 1.85B |
| 197 | TARS | Tarsus Pharmaceuticals, Inc. | 2.98B | - | 370,831 | 451.36M |
| 198 | ALMS | Alumis Inc. | 2.97B | - | 1,412,367 | 24.05M |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 2.93B | - | 1,092,242 | 376.07M |
| 200 | VERA | Vera Therapeutics, Inc. | 2.92B | - | 706,602 | - |
| 201 | SUPN | Supernus Pharmaceuticals, Inc. | 2.91B | - | 472,496 | 718.95M |
| 202 | RCUS | Arcus Biosciences, Inc. | 2.88B | - | 1,576,105 | 247.00M |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 2.88B | - | 694,228 | 218.71M |
| 204 | TXG | 10x Genomics, Inc. | 2.85B | - | 1,277,555 | 642.82M |
| 205 | TVTX | Travere Therapeutics, Inc. | 2.81B | - | 1,149,781 | 490.73M |
| 206 | CON | Concentra Group Holdings Parent, Inc. | 2.68B | - | 539,000 | 2.16B |
| 207 | PRVA | Privia Health Group, Inc. | 2.66B | - | 724,598 | 2.12B |
| 208 | ORKA | Oruka Therapeutics, Inc. | 2.64B | - | 1,638,246 | - |
| 209 | HAE | Haemonetics Corporation | 2.64B | - | 426,369 | 1.32B |
| 210 | VCYT | Veracyte, Inc. | 2.56B | - | 702,900 | 517.15M |
| 211 | NHC | National HealthCare Corporation | 2.53B | - | 95,621 | 1.52B |
| 212 | KOD | Kodiak Sciences Inc. | 2.51B | - | 1,696,829 | - |
| 213 | HCM | HUTCHMED (China) Limited | 2.49B | - | 36,062 | 548.51M |
| 214 | IRON | Disc Medicine, Inc. | 2.49B | - | 570,244 | - |
| 215 | WRBY | Warby Parker Inc. | 2.48B | - | 2,367,672 | 871.91M |
| 216 | PBH | Prestige Consumer Healthcare Inc. | 2.48B | - | 1,594,938 | 1.10B |
| 217 | LMAT | LeMaitre Vascular, Inc. | 2.47B | - | 140,449 | 249.60M |
| 218 | IMNM | Immunome, Inc. | 2.47B | - | 1,602,438 | 6.94M |
| 219 | LFST | LifeStance Health Group, Inc. | 2.46B | - | 1,473,566 | 1.42B |
| 220 | BEAM | Beam Therapeutics Inc. | 2.45B | - | 1,853,979 | 139.74M |
| 221 | AAPG | Ascentage Pharma Group International | 2.44B | - | 6,548 | 82.08M |
| 222 | SRPT | Sarepta Therapeutics, Inc. | 2.44B | 4.97% | 3,157,599 | 2.20B |
| 223 | GRDN | Guardian Pharmacy Services, Inc. | 2.41B | - | 560,972 | 1.45B |
| 224 | MANE | Veradermics, Incorporated | 2.40B | - | 839,650 | - |
| 225 | CLDX | Celldex Therapeutics, Inc. | 2.39B | - | 5,167,187 | 1.55M |
| 226 | ELVN | Enliven Therapeutics, Inc. | 2.32B | - | 810,858 | - |
| 227 | XRAY | DENTSPLY SIRONA Inc. | 2.32B | - | 2,456,150 | 3.68B |
| 228 | ZLAB | Zai Lab Limited | 2.30B | - | 707,426 | 460.16M |
| 229 | ADPT | Adaptive Biotechnologies Corporation | 2.28B | - | 1,565,439 | 276.98M |
| 230 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.26B | - | 7,824,922 | 874.84M |
| 231 | GRAL | GRAIL, Inc. | 2.26B | - | 792,403 | 147.17M |
| 232 | PAHC | Phibro Animal Health Corporation | 2.25B | - | 246,520 | 1.46B |
| 233 | RLAY | Relay Therapeutics, Inc. | 2.24B | - | 8,891,909 | 15.36M |
| 234 | MLYS | Mineralys Therapeutics, Inc. | 2.22B | - | 1,645,190 | - |
| 235 | SNDX | Syndax Pharmaceuticals, Inc. | 2.22B | - | 2,093,743 | 172.35M |
| 236 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | - | 1,403,725 | 158.18M |
| 237 | NKTR | Nektar Therapeutics | 2.21B | - | 552,913 | 55.23M |
| 238 | ACHC | Acadia Healthcare Company, Inc. | 2.21B | - | 2,977,196 | 3.31B |
| 239 | RARE | Ultragenyx Pharmaceutical Inc. | 2.20B | - | 1,772,484 | 673.00M |
| 240 | ADMA | ADMA Biologics, Inc. | 2.19B | - | 6,126,506 | 510.17M |
| 241 | TYRA | Tyra Biosciences, Inc. | 2.13B | - | 1,048,229 | - |
| 242 | HTFL | HeartFlow, Inc. | 2.13B | - | 1,818,147 | 176.03M |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.08B | - | 1,259,998 | 283.06M |
| 244 | AGIO | Agios Pharmaceuticals, Inc. | 2.06B | - | 1,425,474 | 54.03M |
| 245 | DFTX | Definium Therapeutics, Inc. | 2.06B | - | 1,957,745 | - |
| 246 | NEOG | Neogen Corporation | 2.05B | - | 2,293,109 | 880.32M |
| 247 | SLNO | Soleno Therapeutics, Inc. | 2.04B | 6.76% | 3,575,161 | 190.41M |
| 248 | SEM | Select Medical Holdings Corporation | 2.03B | - | 980,472 | 5.45B |
| 249 | BHC | Bausch Health Companies Inc. | 1.98B | - | 1,624,940 | 10.27B |
| 250 | GLPG | Galapagos NV | 1.95B | - | 176,234 | 1.31B |
| 251 | WGS | GeneDx Holdings Corp. | 1.94B | - | 338,658 | 427.54M |
| 252 | STOK | Stoke Therapeutics, Inc. | 1.94B | - | 564,305 | 184.42M |
| 253 | VRDN | Viridian Therapeutics, Inc. | 1.93B | - | 3,056,274 | 70.85M |
| 254 | ZYME | Zymeworks Inc. | 1.90B | - | 701,772 | 105.97M |
| 255 | AHG | Akso Health Group | 1.90B | - | 160,433 | 14.84M |
| 256 | MESO | Mesoblast Limited | 1.90B | - | 173,195 | 65.38M |
| 257 | PHVS | Pharvaris N.V. | 1.87B | - | 244,410 | - |
| 258 | OCUL | Ocular Therapeutix, Inc. | 1.85B | - | 4,374,012 | 51.95M |
| 259 | CAPR | Capricor Therapeutics, Inc. | 1.85B | - | 1,225,842 | 11.13M |
| 260 | SION | Sionna Therapeutics, Inc. | 1.82B | - | 527,755 | - |
| 261 | AXGN | Axogen, Inc. | 1.79B | - | 615,488 | 225.21M |
| 262 | PVLA | Palvella Therapeutics, Inc. | 1.77B | - | 335,110 | - |
| 263 | GENB | Generate Biomedicines, Inc. | 1.75B | - | 460,799 | 31.89M |
| 264 | VCEL | Vericel Corporation | 1.74B | - | 1,685,769 | 276.26M |
| 265 | MD | Pediatrix Medical Group, Inc. | 1.72B | - | 729,384 | 1.91B |
| 266 | ESTA | Establishment Labs Holdings Inc. | 1.71B | - | 279,442 | 211.08M |
| 267 | INVA | Innoviva, Inc. | 1.70B | - | 595,083 | 411.33M |
| 268 | ADUS | Addus HomeCare Corporation | 1.66B | - | 268,689 | 1.42B |
| 269 | ANAB | AnaptysBio, Inc. | 1.66B | - | 611,619 | 234.60M |
| 270 | AORT | Artivion, Inc. | 1.66B | - | 448,169 | 441.33M |
| 271 | OGN | Organon & Co. | 1.66B | - | 3,396,809 | 6.22B |
| 272 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.65B | - | 1,285,859 | -665.00K |
| 273 | RXRX | Recursion Pharmaceuticals, Inc. | 1.64B | 1.63% | 9,290,549 | 74.68M |
| 274 | ATEC | Alphatec Holdings, Inc. | 1.64B | - | 2,108,318 | 764.16M |
| 275 | AHCO | AdaptHealth Corp. | 1.64B | - | 1,056,999 | 3.24B |
| 276 | RAPP | Rapport Therapeutics, Inc. | 1.61B | - | 219,496 | - |
| 277 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | - | 523,808 | 868.45M |
| 278 | NRIX | Nurix Therapeutics, Inc. | 1.60B | - | 1,167,303 | 83.98M |
| 279 | INSP | Inspire Medical Systems, Inc. | 1.58B | - | 1,001,549 | 911.98M |
| 280 | OCS | Oculis Holding AG | 1.58B | - | 109,785 | 1.51M |
| 281 | MBX | MBX Biosciences, Inc. | 1.57B | - | 601,684 | - |
| 282 | PLSE | Pulse Biosciences, Inc. | 1.56B | - | 143,560 | 350.00K |
| 283 | IMCR | Immunocore Holdings plc | 1.56B | - | 477,490 | 400.02M |
| 284 | SGRY | Surgery Partners, Inc. | 1.56B | - | 2,141,750 | 3.31B |
| 285 | OMCL | Omnicell, Inc. | 1.55B | - | 353,906 | 1.18B |
| 286 | NTLA | Intellia Therapeutics, Inc. | 1.55B | -1.06% | 2,750,476 | 67.67M |
| 287 | ANIP | ANI Pharmaceuticals, Inc. | 1.55B | - | 275,800 | 883.37M |
| 288 | NBTX | Nanobiotix S.A. | 1.53B | - | 98,739 | 38.27M |
| 289 | TRVI | Trevi Therapeutics, Inc. | 1.53B | - | 1,218,906 | - |
| 290 | DMRA | Damora Therapeutics, Inc. | 1.51B | - | 237,873 | - |
| 291 | NUVB | Nuvation Bio Inc. | 1.51B | - | 2,413,695 | 62.90M |
| 292 | SNDA | Sonida Senior Living, Inc. | 1.50B | - | 582,362 | 336.39M |
| 293 | PRGO | Perrigo Company plc | 1.49B | - | 3,146,744 | 4.25B |
| 294 | UFPT | UFP Technologies, Inc. | 1.48B | - | 207,620 | 602.80M |
| 295 | BHVN | Biohaven Ltd. | 1.47B | - | 2,600,206 | - |
| 296 | ARDX | Ardelyx, Inc. | 1.46B | - | 2,400,587 | 407.32M |
| 297 | ATRC | AtriCure, Inc. | 1.45B | - | 512,138 | 534.53M |
| 298 | VIR | Vir Biotechnology, Inc. | 1.45B | - | 1,727,274 | 68.56M |
| 299 | MAZE | Maze Therapeutics, Inc. | 1.43B | - | 780,450 | 2.50M |
| 300 | PRCT | PROCEPT BioRobotics Corporation | 1.42B | - | 799,220 | 308.05M |
| 301 | IOVA | Iovance Biotherapeutics, Inc. | 1.41B | - | 7,803,480 | 263.50M |
| 302 | SVRA | Savara Inc. | 1.41B | - | 811,621 | - |
| 303 | BCAX | Bicara Therapeutics Inc. | 1.41B | - | 919,828 | - |
| 304 | PGEN | Precigen, Inc. | 1.39B | - | 5,457,993 | 9.68M |
| 305 | IMTX | Immatics N.V. | 1.39B | - | 440,054 | 56.67M |
| 306 | AVAH | Aveanna Healthcare Holdings Inc. | 1.39B | - | 721,959 | 2.43B |
| 307 | ATAI | AtaiBeckley Inc. | 1.38B | - | 3,055,073 | 4.09M |
| 308 | WVE | Wave Life Sciences Ltd. | 1.37B | - | 4,068,718 | 42.73M |
| 309 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | - | 1,240,324 | 123.67M |
| 310 | HROW | Harrow, Inc. | 1.31B | - | 344,224 | 272.30M |
| 311 | OLMA | Olema Pharmaceuticals, Inc. | 1.31B | - | 904,353 | - |
| 312 | PGNY | Progyny, Inc. | 1.30B | - | 1,157,571 | 1.29B |
| 313 | ENOV | Enovis Corporation | 1.30B | - | 609,074 | 2.25B |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.29B | - | 671,628 | 1.84B |
| 315 | ZBIO | Zenas BioPharma, Inc. | 1.28B | - | 1,722,639 | 10.00M |
| 316 | TNDM | Tandem Diabetes Care, Inc. | 1.27B | - | 1,034,184 | 1.01B |
| 317 | TSHA | Taysha Gene Therapies, Inc. | 1.26B | - | 1,581,008 | 9.77M |
| 318 | NVAX | Novavax, Inc. | 1.25B | - | 4,662,730 | 1.12B |
| 319 | MLTX | MoonLake Immunotherapeutics | 1.25B | - | 1,687,063 | - |
| 320 | ASTH | Astrana Health, Inc. | 1.24B | - | 302,665 | 3.18B |
| 321 | ARDT | Ardent Health, Inc. | 1.24B | - | 300,494 | 6.32B |
| 322 | CRVS | Corvus Pharmaceuticals, Inc. | 1.23B | - | 660,473 | - |
| 323 | IRMD | IRADIMED CORPORATION | 1.23B | - | 79,049 | 83.81M |
| 324 | NVCR | NovoCure Limited | 1.20B | - | 1,154,360 | 655.35M |
| 325 | QDEL | QuidelOrtho Corporation | 1.17B | - | 1,180,176 | 2.73B |
| 326 | DBVT | DBV Technologies S.A. | 1.17B | - | 446,576 | 5.64M |
| 327 | PHAR | Pharming Group N.V. | 1.16B | - | 41,591 | 376.13M |
| 328 | KMTS | Kestra Medical Technologies, Ltd. | 1.16B | - | 388,016 | 83.72M |
| 329 | ALVO | Alvotech | 1.14B | - | 246,833 | 588.90M |
| 330 | NNNN | Anbio Biotechnology | 1.13B | - | 26,086 | 6.92M |
| 331 | SEPN | Septerna, Inc. | 1.13B | - | 288,093 | 45.95M |
| 332 | EYPT | EyePoint, Inc. | 1.12B | - | 1,154,744 | 31.37M |
| 333 | USPH | U.S. Physical Therapy, Inc. | 1.12B | - | 103,369 | 773.34M |
| 334 | AVBP | ArriVent BioPharma, Inc. | 1.10B | - | 362,943 | - |
| 335 | QURE | uniQure N.V. | 1.07B | - | 1,193,029 | 16.10M |
| 336 | CNMD | CONMED Corporation | 1.07B | - | 395,247 | 1.37B |
| 337 | ABCL | AbCellera Biologics Inc. | 1.07B | - | 3,490,358 | 75.13M |
| 338 | GERN | Geron Corporation | 1.06B | - | 33,581,583 | 183.88M |
| 339 | BFLY | Butterfly Network, Inc. | 1.05B | - | 3,686,756 | 97.61M |
| 340 | AZTA | Azenta, Inc. | 1.04B | - | 1,111,405 | 595.03M |
| 341 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | - | 1,338,753 | 291.85M |
| 342 | IVA | Inventiva S.A. | 1.04B | - | 321,490 | 9.31M |
| 343 | NEO | NeoGenomics, Inc. | 1.04B | - | 1,794,520 | 727.33M |
| 344 | PNTG | The Pennant Group, Inc. | 1.04B | - | 250,816 | 947.71M |
| 345 | INNV | InnovAge Holding Corp. | 1.03B | -5.11% | 276,598 | 915.37M |
| 346 | COLL | Collegium Pharmaceutical, Inc. | 1.03B | - | 583,693 | 780.57M |
| 347 | KALV | KalVista Pharmaceuticals, Inc. | 1.02B | - | 910,772 | 73.62M |
| 348 | STAA | STAAR Surgical Company | 1.00B | - | 961,412 | 239.44M |
| 349 | SSII | SS Innovations International, Inc. | 999.70M | - | 48,570 | 42.48M |
| 350 | CTMX | CytomX Therapeutics, Inc. | 985.77M | - | 4,718,182 | 76.20M |
| 351 | CMPX | Compass Therapeutics, Inc. | 981.48M | - | 3,183,387 | 850.00K |
| 352 | VOR | Vor Biopharma Inc. | 978.05M | - | 1,525,854 | - |
| 353 | AKTS | Aktis Oncology, Inc. | 960.14M | - | 380,427 | 6.50M |
| 354 | CRON | Cronos Group Inc. | 958.86M | - | 640,301 | 146.59M |
| 355 | BLFS | BioLife Solutions, Inc. | 942.33M | - | 209,436 | 96.21M |
| 356 | TDOC | Teladoc Health, Inc. | 940.15M | - | 3,494,684 | 2.53B |
| 357 | XNCR | Xencor, Inc. | 939.47M | - | 608,555 | 125.58M |
| 358 | CDNA | CareDx, Inc. | 937.77M | - | 341,886 | 379.81M |
| 359 | MPLT | MapLight Therapeutics, Inc. | 931.99M | - | 146,588 | - |
| 360 | INBX | Inhibrx Biosciences, Inc. | 927.98M | - | 190,000 | 1.30M |
| 361 | AMPH | Amphastar Pharmaceuticals, Inc. | 927.82M | - | 390,454 | 719.89M |
| 362 | EVO | Evotec SE | 921.82M | 1.97% | 88,687 | 887.40M |
| 363 | PCRX | Pacira BioSciences, Inc. | 919.12M | - | 750,441 | 726.41M |
| 364 | URGN | UroGen Pharma Ltd. | 916.20M | - | 382,344 | 109.79M |
| 365 | GHRS | GH Research PLC | 903.77M | - | 102,677 | - |
| 366 | JANX | Janux Therapeutics, Inc. | 902.74M | - | 1,305,022 | 10.00M |
| 367 | CLOV | Clover Health Investments, Corp. | 902.43M | - | 3,285,983 | 1.92B |
| 368 | LMRI | Lumexa Imaging Holdings, Inc. | 898.63M | - | 1,010,822 | 1.02B |
| 369 | PHAT | Phathom Pharmaceuticals, Inc. | 893.58M | - | 786,347 | 175.11M |
| 370 | ORIC | ORIC Pharmaceuticals, Inc. | 892.18M | 18.85% | 7,289,337 | - |
| 371 | FTRE | Fortrea Holdings Inc. | 883.58M | - | 845,544 | 2.72B |
| 372 | ANNX | Annexon, Inc. | 882.61M | - | 3,331,285 | - |
| 373 | ABUS | Arbutus Biopharma Corporation | 875.74M | - | 612,471 | 14.08M |
| 374 | INMD | InMode Ltd. | 873.72M | - | 661,914 | 370.50M |
| 375 | CGEM | Cullinan Therapeutics, Inc. | 873.39M | - | 1,149,608 | - |
| 376 | TALK | Talkspace, Inc. | 865.45M | - | 1,670,561 | 228.87M |
| 377 | OPK | OPKO Health, Inc. | 865.34M | - | 1,157,826 | 606.88M |
| 378 | CERT | Certara, Inc. | 860.95M | - | 6,252,431 | 418.84M |
| 379 | SDGR | Schrödinger, Inc. | 854.89M | - | 781,726 | 255.87M |
| 380 | EVMN | Evommune, Inc. | 854.36M | - | 380,647 | 13.00M |
| 381 | SANA | Sana Biotechnology, Inc. | 853.97M | - | 3,285,581 | - |
| 382 | TBPH | Theravance Biopharma, Inc. | 824.92M | - | 508,782 | 107.46M |
| 383 | SPRY | ARS Pharmaceuticals, Inc. | 824.17M | - | 1,277,290 | 84.28M |
| 384 | OMER | Omeros Corporation | 784.76M | - | 1,837,300 | - |
| 385 | BIOA | BioAge Labs, Inc. | 776.65M | - | 301,371 | 9.00M |
| 386 | MNKD | MannKind Corporation | 770.25M | - | 3,758,383 | 348.97M |
| 387 | JBIO | Jade Biosciences, Inc. | 763.91M | - | 403,279 | - |
| 388 | TLRY | Tilray Brands, Inc. | 763.12M | 6.68% | 5,709,474 | 858.28M |
| 389 | KURA | Kura Oncology, Inc. | 760.52M | - | 4,391,977 | 67.48M |
| 390 | MRVI | Maravai LifeSciences Holdings, Inc. | 758.35M | - | 1,751,631 | 185.74M |
| 391 | TENX | Tenax Therapeutics, Inc. | 755.26M | - | 335,121 | - |
| 392 | SGP | SpyGlass Pharma, Inc. | 750.76M | - | 137,963 | - |
| 393 | MGTX | MeiraGTx Holdings plc | 747.68M | - | 1,094,807 | 81.39M |
| 394 | CMPS | COMPASS Pathways plc | 746.47M | - | 1,310,927 | - |
| 395 | BVS | Bioventus Inc. | 745.90M | - | 318,387 | 568.09M |
| 396 | IART | Integra LifeSciences Holdings Corporation | 742.74M | - | 634,474 | 1.64B |
| 397 | SLS | SELLAS Life Sciences Group, Inc. | 741.68M | - | 4,872,646 | - |
| 398 | OMDA | Omada Health, Inc. | 741.28M | - | 1,036,119 | 260.21M |
| 399 | CSTL | Castle Biosciences, Inc. | 738.52M | - | 288,515 | 344.23M |
| 400 | SLDB | Solid Biosciences Inc. | 736.95M | - | 808,779 | - |
| 401 | RLMD | Relmada Therapeutics, Inc. | 733.18M | - | 1,846,131 | - |
| 402 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 713.09M | - | 164,855 | - |
| 403 | EHAB | Enhabit, Inc. | 710.13M | - | 1,005,413 | 1.06B |
| 404 | AMN | AMN Healthcare Services, Inc. | 703.54M | - | 951,852 | 2.73B |
| 405 | NUTX | Nutex Health Inc. | 703.25M | - | 172,498 | 875.26M |
| 406 | GDRX | GoodRx Holdings, Inc. | 702.28M | - | 1,004,949 | 796.85M |
| 407 | CBLL | CeriBell, Inc. | 699.00M | - | 217,757 | 89.06M |
| 408 | REPL | Replimune Group, Inc. | 694.44M | 10.51% | 3,185,142 | - |
| 409 | ARVN | Arvinas, Inc. | 693.98M | - | 1,289,359 | 262.60M |
| 410 | DSGN | Design Therapeutics, Inc. | 692.58M | - | 314,296 | - |
| 411 | ANRO | Alto Neuroscience, Inc. | 692.58M | - | 710,509 | - |
| 412 | DRUG | Bright Minds Biosciences Inc. | 689.00M | - | 188,468 | - |
| 413 | PSNL | Personalis, Inc. | 688.48M | - | 978,068 | 69.65M |
| 414 | ETON | Eton Pharmaceuticals, Inc. | 681.84M | - | 472,326 | 79.95M |
| 415 | LXRX | Lexicon Pharmaceuticals, Inc. | 673.65M | - | 2,316,350 | 49.80M |
| 416 | ESPR | Esperion Therapeutics, Inc. | 670.28M | - | 5,845,376 | 403.14M |
| 417 | GYRE | Gyre Therapeutics, Inc. | 650.16M | - | 63,540 | 116.59M |
| 418 | LBRX | LB Pharmaceuticals Inc | 649.93M | - | 342,090 | - |
| 419 | AVNS | Avanos Medical, Inc. | 648.78M | - | 334,445 | 701.20M |
| 420 | CBIO | Crescent Biopharma, Inc. | 644.35M | - | 209,010 | 10.84M |
| 421 | DRTS | Alpha Tau Medical Ltd. | 609.03M | - | 168,396 | - |
| 422 | OCGN | Ocugen, Inc. | 604.84M | - | 5,037,360 | 4.41M |
| 423 | ALLO | Allogene Therapeutics, Inc. | 604.57M | - | 4,331,502 | 22.00K |
| 424 | HSTM | HealthStream, Inc. | 600.34M | - | 164,977 | 304.06M |
| 425 | PRME | Prime Medicine, Inc. | 587.90M | - | 1,651,407 | 4.63M |
| 426 | ACRS | Aclaris Therapeutics, Inc. | 583.78M | - | 940,068 | 7.83M |
| 427 | MDXG | MiMedx Group, Inc. | 582.38M | - | 1,678,657 | 418.63M |
| 428 | CTKB | Cytek Biosciences, Inc. | 582.33M | - | 436,532 | 201.49M |
| 429 | SIBN | SI-BONE, Inc. | 579.45M | - | 673,231 | 200.93M |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 577.23M | - | 1,888,847 | 296.15M |
| 431 | PROK | ProKidney Corp. | 573.64M | - | 1,053,710 | 893.00K |
| 432 | TECX | Tectonic Therapeutic, Inc. | 573.06M | - | 163,056 | - |
| 433 | ZURA | Zura Bio Limited | 572.13M | - | 444,928 | - |
| 434 | TCMD | Tactile Systems Technology, Inc. | 559.66M | - | 173,082 | 329.52M |
| 435 | CRMD | CorMedix Inc. | 557.31M | - | 1,671,219 | 311.71M |
| 436 | ZVRA | Zevra Therapeutics, Inc. | 551.89M | - | 587,490 | 106.47M |
| 437 | BWAY | BrainsWay Ltd. | 549.05M | - | 248,099 | 52.23M |
| 438 | VALN | Valneva SE | 543.61M | - | 248,390 | 205.07M |
| 439 | KYTX | Kyverna Therapeutics, Inc. | 536.24M | - | 757,061 | - |
| 440 | EIKN | Eikon Therapeutics, Inc. | 535.97M | - | 252,605 | - |
| 441 | FULC | Fulcrum Therapeutics, Inc. | 535.47M | - | 1,012,333 | 80.00M |
| 442 | PRTA | Prothena Corporation plc | 530.79M | - | 849,122 | 9.68M |
| 443 | EMBC | Embecta Corp. | 524.10M | - | 1,084,184 | 1.08B |
| 444 | YDES | YD Bio Limited | 522.48M | - | 8,824 | 510.36K |
| 445 | AGMB | AgomAb Therapeutics NV | 522.46M | - | 185,548 | - |
| 446 | UPB | Upstream Bio, Inc. | 516.99M | - | 537,603 | 2.85M |
| 447 | VTVT | vTv Therapeutics Inc. | 510.90M | - | 40,993 | 17.00K |
| 448 | PHR | Phreesia, Inc. | 508.59M | - | 3,534,550 | 480.59M |
| 449 | RIGL | Rigel Pharmaceuticals, Inc. | 508.57M | - | 186,532 | 294.28M |
| 450 | AVR | Anteris Technologies Global Corp. | 507.04M | - | 527,715 | 1.91M |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 452 | AQST | Aquestive Therapeutics, Inc. | 504.05M | - | 919,131 | 44.55M |
| 453 | CATX | Perspective Therapeutics, Inc. | 502.45M | - | 1,053,849 | 884.00K |
| 454 | CTNM | Contineum Therapeutics, Inc. | 501.80M | - | 111,074 | - |
| 455 | LRMR | Larimar Therapeutics, Inc. | 497.60M | - | 994,381 | - |
| 456 | VSTM | Verastem, Inc. | 494.51M | - | 1,837,872 | 30.91M |
| 457 | LYEL | Lyell Immunopharma, Inc. | 494.34M | - | 88,861 | 36.00K |
| 458 | NPCE | NeuroPace, Inc. | 493.22M | - | 170,501 | 99.99M |
| 459 | FLGT | Fulgent Genetics, Inc. | 485.17M | - | 556,226 | 322.67M |
| 460 | FDMT | 4D Molecular Therapeutics, Inc. | 483.97M | - | 706,932 | 85.21M |
| 461 | ADCT | ADC Therapeutics SA | 480.23M | - | 1,355,063 | 81.36M |
| 462 | FBRX | Forte Biosciences, Inc. | 480.09M | - | 241,649 | - |
| 463 | KMDA | Kamada Ltd. | 477.23M | - | 32,296 | 180.46M |
| 464 | IMMX | Immix Biopharma, Inc. | 473.50M | - | 418,142 | - |
| 465 | TRDA | Entrada Therapeutics, Inc. | 473.40M | - | 178,008 | 25.42M |
| 466 | ABSI | Absci Corporation | 468.25M | - | 4,676,279 | 2.80M |
| 467 | OFIX | Orthofix Medical Inc. | 462.86M | - | 238,831 | 822.31M |
| 468 | ASMB | Assembly Biosciences, Inc. | 460.18M | - | 37,857 | 72.30M |
| 469 | STTK | Shattuck Labs, Inc. | 459.44M | - | 443,022 | 1.00M |
| 470 | AVIR | Atea Pharmaceuticals, Inc. | 458.91M | - | 442,902 | - |
| 471 | ENGN | enGene Holdings Inc. | 448.16M | - | 332,809 | - |
| 472 | MYGN | Myriad Genetics, Inc. | 444.16M | - | 1,147,870 | 824.50M |
| 473 | BBNX | Beta Bionics, Inc. | 440.71M | - | 612,089 | 100.25M |
| 474 | RGNX | REGENXBIO Inc. | 440.26M | - | 420,975 | 170.44M |
| 475 | VREX | Varex Imaging Corporation | 440.15M | - | 152,709 | 854.40M |
| 476 | EPRX | Eupraxia Pharmaceuticals Inc. | 439.78M | - | 259,638 | - |
| 477 | ALT | Altimmune, Inc. | 434.55M | 7.05% | 2,737,035 | 41.00K |
| 478 | ANGO | AngioDynamics, Inc. | 429.74M | - | 1,227,287 | 313.73M |
| 479 | EBS | Emergent BioSolutions Inc. | 425.03M | - | 880,373 | 742.90M |
| 480 | LXEO | Lexeo Therapeutics, Inc. | 423.78M | - | 625,751 | - |
| 481 | AURA | Aura Biosciences, Inc. | 419.54M | - | 175,767 | - |
| 482 | AUNA | Auna S.A. | 418.91M | - | 100,600 | 1.30B |
| 483 | NAUT | Nautilus Biotechnology, Inc. | 418.30M | -1.49% | 218,141 | - |
| 484 | VNDA | Vanda Pharmaceuticals Inc. | 413.76M | - | 920,012 | 216.11M |
| 485 | KIDS | OrthoPediatrics Corp. | 405.98M | - | 114,207 | 236.35M |
| 486 | AVTX | Avalo Therapeutics, Inc. | 404.72M | - | 1,109,152 | 59.00K |
| 487 | PACB | Pacific Biosciences of California, Inc. | 404.68M | - | 6,492,594 | 160.01M |
| 488 | DNA | Ginkgo Bioworks Holdings, Inc. | 401.63M | - | 1,438,261 | 170.16M |
| 489 | CYH | Community Health Systems, Inc. | 396.24M | - | 835,449 | 12.49B |
| 490 | STRO | Sutro Biopharma, Inc. | 393.97M | - | 126,595 | 102.48M |
| 491 | XOMA | XOMA Royalty Corporation | 392.98M | - | 93,568 | 52.15M |
| 492 | LCTX | Lineage Cell Therapeutics, Inc. | 391.07M | - | 581,886 | 14.56M |
| 493 | NRC | National Research Corporation | 390.33M | - | 56,445 | 137.39M |
| 494 | WEAV | Weave Communications, Inc. | 386.16M | - | 1,232,616 | 239.02M |
| 495 | XFOR | X4 Pharmaceuticals, Inc. | 385.50M | - | 206,100 | 35.11M |
| 496 | RCKT | Rocket Pharmaceuticals, Inc. | 385.42M | - | 2,286,672 | - |
| 497 | CGC | Canopy Growth Corporation | 383.14M | 2.63% | 6,866,602 | 203.04M |
| 498 | IPSC | Century Therapeutics, Inc. | 382.81M | - | 678,760 | 109.16M |
| 499 | ENTA | Enanta Pharmaceuticals, Inc. | 381.31M | - | 112,824 | 66.98M |
| 500 | SIGA | SIGA Technologies, Inc. | 375.42M | - | 872,456 | 94.57M |